Back
Credit Acceptance Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
50
CACC
Credit Acceptance
Last Price:
$493.12
Seasonality Move:
8.6%
Sell
25
DRUG
Bright Minds Biosciences
Last Price:
$37.50
Seasonality Move:
-32.13%
Sell
50
Credit Acceptance (CACC)
is a Sell
Is Credit Acceptance a Buy, Sell or Hold?
-
The current Credit Acceptance [CACC] share price is $476.54. The Score for CACC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
CACC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $33.89. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CACC Stock Price Chart
What is Credit Acceptance's stock price today?
-
The Credit Acceptance share price today is $476.54Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CACC is experiencing selling pressure, which indicates risk of future bearish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $33.89The current trend is relatively stagnant and DRUG is experiencing slight buying pressure.
CACC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.79 | Sell |
Relative Strength Index (14 RSI): | 36.45 | Sell |
Chaikin Money Flow: | -40469 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (496.31 - 524.97) | Sell |
Bollinger Bands (100): | (448.62 - 503.08) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 39.44 | Sell |
Chaikin Money Flow: | 2596 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.9 - 42.16) | Sell |
Bollinger Bands (100): | (23.98 - 48.72) | Sell |
CACC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 501.55 | Sell |
20-day SMA: | 508.16 | Sell |
50-day SMA: | 491.01 | Sell |
200-day SMA: | 483.74 | Sell |
8-day EMA: | 493.9 | Sell |
20-day EMA: | 500.9 | Sell |
50-day EMA: | 493.79 | Sell |
200-day EMA: | 486.64 | Sell |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.31 | Sell |
20-day SMA: | 38.38 | Sell |
50-day SMA: | 37.75 | Sell |
200-day SMA: | 18.73 | Buy |
8-day EMA: | 36.19 | Sell |
20-day EMA: | 37.52 | Sell |
50-day EMA: | 37.1 | Sell |
200-day EMA: | 24 | Buy |
Credit Acceptance Earnings Growth & CACC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.10 per share, an increase next quarter of $1.31 per share, an increase this year of $9.36 per share, and an increase next year of $7.45 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $1.55 per share.
Credit Acceptance Technical Analysis
Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
12 | 13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
12 | 13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |